{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T05:49:03Z","timestamp":1786600143428,"version":"build-2736575974"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T00:00:00Z","timestamp":1515715200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf - Case Rep"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s40800-017-0068-6","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T05:53:08Z","timestamp":1515736388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Life-Threatening Reaction with Topical 5-Fluorouracil"],"prefix":"10.1007","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4736-7251","authenticated-orcid":false,"given":"Patrick","family":"Kishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia J.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,12]]},"reference":[{"issue":"8","key":"68_CR1","first-page":"2006","volume":"5","author":"M Johnson","year":"1999","unstructured":"Johnson M, Hageboutros A, Wang K, High L, Smith JB, Diasio RB. Life-threatening toxicity in a dihydropyrimidine dehydrogenase\u2014deficient patient after treatment with topical 5\u2014fluorouracil. Clin Cancer Res. 1999;5(8):2006\u201311.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"68_CR2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/annonc\/mdg056","volume":"14","author":"AB Kuilenburg Van","year":"2003","unstructured":"Van Kuilenburg AB, Baars JW, Meinsma R, van Gennip AH. Lethal 5-fluorouracil toxicity associated with a novel mutation in the dyhydropyrimidine dehydrogenase gene. Ann Oncol. 2003;14(2):341\u20132.","journal-title":"Ann Oncol"},{"issue":"4","key":"68_CR3","first-page":"1531","volume":"34","author":"P Papnastasopoulos","year":"2014","unstructured":"Papnastasopoulos P, Stebbing J. Molecular basis of 5-fluorouracil-related toxicity: lessons from clinical practice. Anticancer Res. 2014;34(4):1531\u20135.","journal-title":"Anticancer Res"},{"issue":"5","key":"68_CR4","first-page":"365","volume":"71","author":"W Tutrone","year":"2003","unstructured":"Tutrone W, Saini R, Selin Caglar, et al. Topical therapy for actinic keratoses, I: 5\u2014fluorouracil and imiquinod. Cutis. 2003;71(5):365\u201370.","journal-title":"Cutis"},{"key":"68_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0065-2571(00)00011-X","volume":"41","author":"M Johnson","year":"2001","unstructured":"Johnson M, Diasio R. Importance of dihydropyrimidine dehydrogenase (DPD) deficiency in patients exhibiting toxicity following treatment with 5-fluorouracil. Adv Enzyme Regul. 2001;41:151\u20137.","journal-title":"Adv Enzyme Regul"},{"issue":"1","key":"68_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1040-8428(98)00036-5","volume":"30","author":"E Gamelin","year":"1999","unstructured":"Gamelin E, Boisdron-Celle MB. Dose monitoring of 5-fluorouracil in patients with colorectal or head and neck cancer \u2013 status of the art. Crit Rev Oncol Hematol. 1999;30(1):71\u20139.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"68_CR7","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1200\/JCO.1998.16.4.1470","volume":"16","author":"E Gamelin","year":"1998","unstructured":"Gamelin E, Boisdron-Celle M, Delva R, Regimbeau C, Cailleux PE, Alleaume C, et al. Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients. J Clin Oncol. 1998;16(4):1470\u20138.","journal-title":"J Clin Oncol"},{"issue":"3","key":"68_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/(SICI)1097-0142(19960201)77:3<441::AID-CNCR4>3.0.CO;2-N","volume":"77","author":"E Gamelin","year":"1996","unstructured":"Gamelin E, Danquechin-Dorval E, Dumesnil Y, Maillart PJ, Goudier MJ, Burtin PC, et al. Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU. Cancer. 1996;77(3):441\u201351.","journal-title":"Cancer"},{"issue":"3","key":"68_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3816\/CCC.2004.n.018","volume":"4","author":"H Ezzeldin","year":"2004","unstructured":"Ezzeldin H, Diasio R. Dihydropyrimidine dehydrogenase deficiency, a pharmacogenetic syndrome associated with potentially life-threatening toxicity following 5-fluorouracil administration. Clin Colorectal Cancer. 2004;4(3):181\u20139.","journal-title":"Clin Colorectal Cancer"}],"container-title":["Drug Safety - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40800-017-0068-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40800-017-0068-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40800-017-0068-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T19:02:50Z","timestamp":1547233370000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40800-017-0068-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,12]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["68"],"URL":"https:\/\/doi.org\/10.1007\/s40800-017-0068-6","relation":{},"ISSN":["2199-1162","2198-977X"],"issn-type":[{"value":"2199-1162","type":"print"},{"value":"2198-977X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,12]]},"assertion":[{"value":"12 January 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and for inclusion of the accompanying images. A copy of the written consent may be requested for review from the corresponding author.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"Patrick Kishi and Cynthia J Price have no conflicts of interest that are directly relevant to the content of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"No sources of funding were used to conduct this study or prepare this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}],"article-number":"4"}}